Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Taro Pharmaceutical Indus...

    NYSE: TARO · Real-Time Price · USD
    42.98
    0.01 (0.02%)
    At close: Jun 21, 2024, 9:59 PM

    Taro Pharmaceutical Industries Income Statement

    Financials in USD. Fiscal year is April - March.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
    Revenue
    		 629.18M 610.83M 592.88M 575.18M 572.95M 569.63M 569.41M 570.9M 561.35M 566.43M 567.59M 578.45M 548.97M 575.56M 583.1M 601.11M
    Cost of Revenue
    		 324.23M 317.55M 315.44M 324.38M 304.63M 299.67M 287.46M 273.87M 268.23M 273.72M 277.73M 269.04M 252.31M 253.57M 240.17M 238.16M
    Gross Profit
    		 304.96M 293.27M 277.44M 250.8M 268.32M 269.96M 281.95M 297.03M 293.12M 292.71M 289.87M 309.41M 296.66M 321.99M 342.93M 362.95M
    Operating Income
    		 21.48M 21.98M 7.37M -1.4M 20.5M 23.3M 58.98M 87.46M 54.25M 295K -362K 16.15M -413.77M -314.68M -292.79M -271.19M
    Interest Income
    		 56.19M 48.39M 39.49M 29.81M 20.85M 13.5M 9M 7.07M 8.19M 10.69M 12.6M 15.91M 20.17M 23.62M 28.15M 31.33M
    Pretax Income
    		 82.67M 74.34M 50.17M 27.6M 38.21M 45.33M 75.66M 109.99M 77.86M 15.08M 14.72M 33.95M -391.07M -284.97M -253.56M -229.75M
    Net Income
    		 53.87M 45.7M 32.76M 21.4M 25.44M 45.94M 64.98M 91.11M 58.27M 1.08M 7.68M 29.5M -386.65M -302.67M -267.91M -256.86M
    Selling & General & Admin
    		 218.94M 210.94M 210.39M 198.1M 198.37M 189.41M 164.39M 145.82M 113.68M 94.73M 92.69M 93.08M 91.35M 98.23M 96.36M 95.94M
    Research & Development
    		 64.54M 60.36M 59.68M 56.88M 52.24M 50.83M 52.12M 53.1M 54.54M 56.23M 56.12M 60.17M 60.15M 59.36M 60.28M 59.27M
    Other Expenses
    		 956K 956K 1.52M 1.35M 1.4M 1.92M 1.35M 957K 512K 100K 100K 100K 100K n/a n/a n/a
    Operating Expenses
    		 283.47M 271.3M 270.07M 254.99M 250.61M 240.24M 216.52M 198.92M 168.22M 150.97M 148.81M 153.25M 151.51M 157.59M 156.64M 155.06M
    Interest Expense
    		 n/a n/a 6.76M 11.05M 12.98M 13.67M 9M 7.07M 8.19M 10.69M 12.6M 15.91M 12.86M 16.31M 20.84M 24.02M
    Selling & Marketing Expenses
    		 n/a 14.51M 14.51M 14.51M 14.51M 8.28M 8.28M 8.28M 8.28M 5.68M 5.68M 5.68M 5.68M 4.9M 4.9M 4.9M
    Cost & Expenses
    		 607.7M 588.85M 585.51M 579.37M 555.24M 539.91M 503.98M 472.79M 436.44M 424.69M 426.53M 422.3M 403.82M 411.16M 396.81M 393.22M
    Income Tax Expense
    		 28.8M 28.64M 17.41M 6.2M 12.77M -607K 10.67M 18.88M 19.59M 13.1M 6.01M 3.5M 9.67M 32.47M 29.24M 41.89M
    Shares Outstanding (Basic)
    		 37.58M 37.58M 37.58M 37.58M 37.58M 37.58M 37.58M 37.58M 37.58M 37.58M 37.6M 37.53M 38.07M 38.25M 38.26M 38.25M
    Shares Outstanding (Diluted)
    		 37.58M 37.58M 37.58M 37.58M 37.58M 37.58M 37.58M 37.58M 37.58M 37.58M 37.6M 37.79M 38.07M 38.25M 38.26M 38.26M
    EPS (Basic)
    		 1.44 1.22 0.87 0.57 0.67 1.22 1.73 2.42 1.55 0.04 0.20 0.76 -10.11 -7.91 -7.01 -6.73
    EPS (Diluted)
    		 1.44 1.22 0.87 0.57 0.67 1.22 1.73 2.42 1.55 0.04 0.20 0.76 -10.11 -7.91 -7.01 -6.73
    EBITDA
    		 61.32M 63.34M 48.09M 37.11M 52.19M 60.05M 96.2M 126.68M 146.2M 76.37M 76.67M 89.32M -400.6M -304.89M -288.86M -266.79M
    EBIT
    		 30.23M 40M 40.18M 33.2M 52.91M 58.99M 84.66M 117.06M 86.05M 25.77M 27.32M 49.86M -385.52M -275.97M -240.03M -212.89M
    Depreciation & Amortization
    		 31.09M 23.34M 8.64M 8.05M 7.43M 13.63M 27.41M 26.84M 25.91M 25.59M 25.11M 24.45M 23.68M 22.62M 22.09M 21.88M

    Add to Watchlist